Physician

Daniel Joseph Hansen, DO

According to 2025 Medicare claims, Daniel Hansen, DO (NPI: 1114121217) practices dermatology in the Ogden, UT market, with the plurality of this provider's patient population coming from Weber, UT. This provider's primary affiliated billing organization is DANIEL J. HANSEN, D.O., PLLC (NPI: 1447485123; TIN: 270212896) and primary practice location at 84405-4976.

Hansen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 729 traditional Medicare patients, billed 4,592 HCPCS/CPT codes, and received $271,584 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 840 prescription claims across 314 beneficiaries totaling $433,889 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 21 records totaling $417. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $35,019 to $433,889. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$223K$445K2015 Medicare payment: $271,574 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $333,247 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $445,293 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $432,322 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $417,971 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $377,322 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $366,187 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $319,518 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $299,408 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $271,584 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0156,850$271,574
20161,1658,291$333,247
20171,33310,200$445,293
20181,33013,860$432,322
20191,28811,602$417,971
20201,1618,234$377,322
20211,0237,153$366,187
20228665,808$319,518
20238154,968$299,408
20247294,592$271,584

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$217K$434K2015 Drug cost: $35,019 (USD; Tot_Drug_Cst)2016 Drug cost: $184,288 (USD; Tot_Drug_Cst)2017 Drug cost: $85,917 (USD; Tot_Drug_Cst)2018 Drug cost: $97,802 (USD; Tot_Drug_Cst)2019 Drug cost: $380,080 (USD; Tot_Drug_Cst)2020 Drug cost: $271,116 (USD; Tot_Drug_Cst)2021 Drug cost: $215,830 (USD; Tot_Drug_Cst)2022 Drug cost: $244,843 (USD; Tot_Drug_Cst)2023 Drug cost: $260,008 (USD; Tot_Drug_Cst)2024 Drug cost: $433,889 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015181395$35,019
2016185448$184,288
2017216523$85,917
2018183400$97,802
2019191403$380,080
2020215483$271,116
2021222490$215,830
2022249532$244,843
2023268617$260,008
2024314840$433,889

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths251298$75
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more588877$59
88305Pathology examination of tissue using a microscope, intermediate complexity198302$56
17000Destruction of precancer skin growth, 1 growth334467$35
17003Destruction of precancer skin growth, 2-14 growths2501,378$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab14392$99,307
Dupixent SyringeDupilumab17462$75,258
Betamethasone DipropionateBetamethasone Dipropionate932,310$2,975
FluorouracilFluorouracil34984$2,546
Clobetasol PropionateClobetasol Propionate20572$1,760

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$417ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel Joseph Hansen, DO?

Tedicare shows public-source Medicare data for Daniel Joseph Hansen, DO (NPI 1114121217), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Joseph Hansen, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Joseph Hansen, DO?

Daniel Joseph Hansen, DO is linked to DANIEL J. HANSEN, D.O., PLLC (billing NPI 1447485123) in the available physician profile data.

Does Daniel Joseph Hansen, DO have Open Payments data?

Daniel Joseph Hansen, DO has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.